B

Blue Arbor Technologies

HealthProstheticsB2B

Blue Arbor Technologies is developing the RESTORE Neuromuscular Interface System, designed for independent and simultaneous control of prosthetic limbs. The company is advancing both external and implantable versions of its sensing interface. This funding will support feasibility studies and regulatory efforts for clinical trials.

Total raised
Undisclosed
tracked to date
Latest round
Series A
Oct 30, 2026
Known investors
1
led by Ottobock

Is this your company?

Claim this profile to get matched with investors who fund Health startups.

Claim this profile →

Funding history

  1. 1
    10.5 million US-dollarSeries AOct 30, 2026

    Led by Ottobock

    Announcement ↗

Investors in Blue Arbor Technologies

Backers from this company's tracked funding rounds.

  • OOttobockLead investorVC firm

Blue Arbor Technologies in the news

Coverage of this company's funding, tracked by Datapile.

More Health companies

Recently funded startups in the same category.

Related on Datapile